HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gorenstein, L. A. Articles by Roth, J. A. Search for Related Content PubMed PubMed Citation Articles by Gorenstein, L. A. Articles by Roth, J. A.

The Annals of Thoracic Surgery, Vol 52, 204-210, Copyright © 1991 by The Society of Thoracic Surgeons

ARTICLES

Improved survival after resection of pulmonary metastases from malignant melanoma

LA Gorenstein, JB Putnam, G Natarajan, CA Balch and JA Roth
Department of Thoracic Surgery, University of Texas M.D. Anderson Cancer Center, Houston 77030-4009.

The value of resecting pulmonary metastases from malignant melanoma was retrospectively examined. Between 1981 and 1989, 56 patients (35 men and 21 women with a mean age of 49 years) had 65 pulmonary resections for histologically proven metastatic melanoma after treatment of the primary tumor. In patients undergoing thoracotomy, 50% (28/56) had pulmonary metastases as the initial site of recurrence. Twenty-eight patients (50%) had local-regional recurrence before the development of lung metastases. Eight lobectomies, two segmentectomies, and 55 wedge excisions were done. Fifty-four patients (54/56, 96%) underwent complete resection, and there were no operative deaths. The postthoracotomy actuarial survival was 25% at 5 years (median interval, 18 months). Location of the primary tumor, histology, thickness, Clark level, local-regional lymph node metastases, or type of resection was not associated with improved survival. Patients without regional nodal metastases before thoracotomy had a median survival of 30 months compared with 16 months for all others (p = 0.04). Patients with lung as the site of first recurrence had a median survival of 30 months compared with 17 months for patients with initial local-regional recurrence (p = 0.038, log-rank test). Despite systemic spread, patients with isolated pulmonary metastases from melanoma may benefit from metastasectomy.

This article has been cited by other articles:

				H. B. Neuman, A. Patel, C. Hanlon, J. D. Wolchok, A. N. Houghton, and D. G. Coit Stage-IV Melanoma and Pulmonary Metastases: Factors Predictive of Survival Ann. Surg. Oncol., October 1, 2007; 14(10): 2847 - 2853. [Abstract] [Full Text] [PDF]

				R. P. Petersen, S. I. Hanish, J. C. Haney, C. C. Miller III, W. R. Burfeind Jr, D. S. Tyler, H. F. Seigler, W. Wolfe, T. A. D'Amico, and D. H. Harpole Jr Improved survival with pulmonary metastasectomy: An analysis of 1720 patients with pulmonary metastatic melanoma J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 104 - 110. [Abstract] [Full Text] [PDF]

				H. Tsao, M. Feldman, J. E. Fullerton, A. J. Sober, D. Rosenthal, and W. Goggins Early Detection of Asymptomatic Pulmonary Melanoma Metastases by Routine Chest Radiographs Is Not Associated With Improved Survival Arch Dermatol, January 1, 2004; 140(1): 67 - 70. [Abstract] [Full Text] [PDF]

				E. C. Hsueh, R. Essner, L. J. Foshag, D. W. Ollila, G. Gammon, S. J. O'Day, P. D. Boasberg, S. L. Stern, X. Ye, and D. L. Morton Prolonged Survival After Complete Resection of Disseminated Melanoma and Active Immunotherapy With a Therapeutic Cancer Vaccine J. Clin. Oncol., December 1, 2002; 20(23): 4549 - 4554. [Abstract] [Full Text] [PDF]

				P. J. Allen and D. G. Coit The Surgical Management of Metastatic Melanoma Ann. Surg. Oncol., October 1, 2002; 9(8): 762 - 770. [Abstract] [Full Text] [PDF]

				J. B. Zwischenberger and S. K. Alpard Pulmonary metastasectomy Ann. Thorac. Surg., July 1, 1999; 68(1): 287 - 288. [Full Text] [PDF]

				L. Tafra, P. S. Dale, L. A. Wanek, K. P. Ramming, and D. L. Morton Resection and adjuvant immunotherapy for melanoma metastatic to the lung and thorax J. Thorac. Cardiovasc. Surg., July 1, 1995; 110(1): 119 - 129. [Abstract] [Full Text]